Insider Transactions in Q4 2025 at Lexeo Therapeutics, Inc. (LXEO)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 17
2025
|
Richard Nolan Townsend Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,133
-2.57%
|
$118,197
$9.25 P/Share
|
|
Oct 17
2025
|
Eric Adler Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,382
-2.21%
|
$30,438
$9.25 P/Share
|
|
Oct 17
2025
|
Jose Manuel Otero Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,115
-1.6%
|
$19,035
$9.25 P/Share
|
|
Oct 17
2025
|
Jenny Robertson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,526
-2.43%
|
$31,734
$9.25 P/Share
|
|
Oct 17
2025
|
Tai Sandi See Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,888
-2.79%
|
$34,992
$9.25 P/Share
|
|
Oct 15
2025
|
Richard Nolan Townsend Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,000
+11.45%
|
-
|
|
Oct 15
2025
|
Eric Adler Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,570
+11.1%
|
-
|
|
Oct 15
2025
|
Jose Manuel Otero Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,940
+8.22%
|
-
|
|
Oct 15
2025
|
Jenny Robertson Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,900
+12.02%
|
-
|
|
Oct 15
2025
|
Tai Sandi See Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,890
+13.5%
|
-
|